Vitamin K Antagonists Predispose to Calciphylaxis in Patients with End-Stage Renal Disease

Publisher： Karger

E-ISSN： 2235-3186|129|3|197-201

ISSN： 1660-8151

Source： Nephron, Vol.129, Iss.3, 2015-02, pp. : 197-201

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mineralocorticoid Receptor Antagonists in End-Stage Renal Disease: Efficacy and Safety

By  

Blood Purification, Vol. 41, Iss. 1-3, 2016-01 ,pp. : 166-170

Karger

Access to resources Recommend Favorite

Angiotensin-Converting Enzyme Inhibitors but Not Angiotensin II AT 1 Receptor Antagonists Affect Erythropoiesis in Patients with Anemia of End-Stage Renal Disease

By  

Nephron, Vol. 81, Iss. 1, 1999-01 ,pp. : 106-108

Karger

Access to resources Recommend Favorite

Keloids and End-Stage Renal Disease

By  

Nephron, Vol. 80, Iss. 2, 1998-09 ,pp. : 244-246

Karger

Access to resources Recommend Favorite

Arterial Stiffness and Walk Time in Patients with End-Stage Renal Disease

By  

Kidney and Blood Pressure Research, Vol. 37, Iss. 2-3, 2013-04 ,pp. : 142-150

Karger

Access to resources Recommend Favorite

Serum Levels of Omentin in End-Stage Renal Disease Patients

By  

Kidney and Blood Pressure Research, Vol. 35, Iss. 6, 2012-07 ,pp. : 511-516

Karger

Access to resources Recommend Favorite